Using Sequencing and AI for Infectious Disease Detection

Day Zero Diagnostics (DZD) is seeking to develop a more effective way of detecting infectious disease using artificial intelligence and genome sequencing. The Boston-based company announced it has raised $8.6 million in its mission to further develop the test. DZD's series A round was led by Triventures with significant participation from existing investors including Sands Capital Ventures and Golden Seeds. With the financing, the company will accelerate prototype development of its sam...

from A via a.sfakia on Inoreader http://bit.ly/2Uq9qFQ